Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

NCT01404312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis
HIV Infections

Interventions

DRUG: Rifapentine (RPT)
DRUG: Isoniazid (INH)
DIETARY_SUPPLEMENT: Pyridoxine (Vitamin B6)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)